Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco
NCT02979002 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 219
Last updated 2017-08-08
Summary
The aim of this study is to estimate the accuracy of CL Detect Rapid Test™ compared to a composite reference standard test (Direct examination of skin smears + PCR test) in patients with clinically suspected Cutaneous Leishmaniasis disease in Morocco.
Conditions
- Cutaneous Leishmaniasis
- Skin Diseases, Parasitic
- Neglected Diseases
Sponsors & Collaborators
-
Institute of Tropical Medicine, Belgium
collaborator OTHER -
National School of Public Health, Morocco
lead OTHER
Principal Investigators
-
Issam Bennis, MD, MPH · National School of Public Health - Rabat - Morocco
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2017-08-31
- Completion
- 2017-08-31
Countries
- Morocco
Study Locations
More Related Trials
-
ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -
NCT03303898 ·Status: COMPLETED ·Phase: NA
-
Clinical Investigation of Infections Due to Leishmanial Parasites
NCT00001169 ·Status: COMPLETED
-
Diagnosis and Treatment of Leishmania Infections
NCT00344188 ·Status: RECRUITING
-
Low Antimonial Dosage in American Mucosal Leishmaniasis
NCT01301937 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the Disease
NCT06692985 ·Status: COMPLETED
-
Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
NCT01301924 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan
NCT05449717 ·Status: COMPLETED
-
Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure
NCT05426577 ·Status: UNKNOWN
-
Clinical Prognostic Score to Predict Relapse in VL
NCT05602610 ·Status: RECRUITING
-
Mediterranean Visceral Leishmaniasis With Leishmania Infantum
NCT03784248 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)
NCT01975051 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)
NCT00600548 ·Status: COMPLETED ·Phase: PHASE2
-
Liposomal Amphotericin in Disseminated Leishmaniasis
NCT02025491 ·Status: COMPLETED ·Phase: PHASE3
-
Performance of RPA-LF for Cutaneous Leishmaniasis
NCT04500873 ·Status: COMPLETED
-
Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study
NCT06118749 ·Status: TERMINATED
-
LAMP Assay for the Diagnosis of Visceral Leishmaniasis
NCT04003532 ·Status: COMPLETED
-
ELISA Validation of Hypersensitive Rapid Diagnostic Test Results for Detection of P. Falciparum
NCT03132402 ·Status: COMPLETED
-
Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil
NCT01310738 ·Status: TERMINATED ·Phase: PHASE4
-
Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis
NCT06011343 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
NCT01032187 ·Status: COMPLETED ·Phase: PHASE4
-
Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.
NCT06000514 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients
NCT03084952 ·Status: UNKNOWN ·Phase: PHASE2
-
Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
NCT00537953 ·Status: UNKNOWN ·Phase: PHASE2
-
Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
NCT00257530 ·Status: COMPLETED ·Phase: PHASE3
-
Immunization With Different Doses of Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis
NCT01218893 ·Status: COMPLETED ·Phase: NA